TY - JOUR
T1 - Effect of rapamycin on cytokine profile in kidney transplant recipients treated with triple drug therapy
AU - Morales-Buenrostro, L. E.
AU - Llorente, L.
AU - Richaud-Patin, Y.
AU - De Leo, C.
AU - Soto-Vega, E.
AU - Diáz-Alderete, A.
AU - Vázquez-Lavista, L. G.
AU - Coto, S.
AU - Correa-Rotter, R.
AU - Alberú, J.
PY - 2004/7/1
Y1 - 2004/7/1
N2 - The aim of this study was to explore differences in the cytokine profile among de novo kidney transplant recipients treated with either Rapamycin (Rapa) + cyclosporine (CsA) + prednisone (P) or CsA + azathioprine (Aza) + P. Among the 13 adult kidney transplant recipients studied, seven received Rapa + CsA + P while the remaining six received CsA + Aza + P with their living donors serving as controls (n = 13). Spontaneous production of IL-2, IFNγ, IL-10, and TGF-β were measured by ELISA in supernatants from 24-hour cultured unstimulated peripheral blood mononuclear cell (PBMC) at time zero (the day before the transplant), and at 3 and 6 months posttransplant. Cytokines were also measured 1 month after CsA withdrawal in the Rapa + CsA + P group. From time zero to the end of the study, IL-2, IFNγ, and IL-10 were present at low or undetectable levels in all three groups. TGF-β tended to increase in supernatants from patients under Rapa + CsA + P at 6 months posttransplant and at 1 month after CsA withdrawal without correlation to Rapa blood levels. TGF-β remained stable throughout the study period for patients included in the CsA + Aza + P group. There was no difference in this cytokine level between these study groups at any given time. This study showed no differences in the spontaneous cytokine profiles evaluated in patients treated with both therapeutic schemes.
AB - The aim of this study was to explore differences in the cytokine profile among de novo kidney transplant recipients treated with either Rapamycin (Rapa) + cyclosporine (CsA) + prednisone (P) or CsA + azathioprine (Aza) + P. Among the 13 adult kidney transplant recipients studied, seven received Rapa + CsA + P while the remaining six received CsA + Aza + P with their living donors serving as controls (n = 13). Spontaneous production of IL-2, IFNγ, IL-10, and TGF-β were measured by ELISA in supernatants from 24-hour cultured unstimulated peripheral blood mononuclear cell (PBMC) at time zero (the day before the transplant), and at 3 and 6 months posttransplant. Cytokines were also measured 1 month after CsA withdrawal in the Rapa + CsA + P group. From time zero to the end of the study, IL-2, IFNγ, and IL-10 were present at low or undetectable levels in all three groups. TGF-β tended to increase in supernatants from patients under Rapa + CsA + P at 6 months posttransplant and at 1 month after CsA withdrawal without correlation to Rapa blood levels. TGF-β remained stable throughout the study period for patients included in the CsA + Aza + P group. There was no difference in this cytokine level between these study groups at any given time. This study showed no differences in the spontaneous cytokine profiles evaluated in patients treated with both therapeutic schemes.
UR - http://www.scopus.com/inward/record.url?scp=4444373657&partnerID=8YFLogxK
U2 - 10.1016/j.transproceed.2004.06.064
DO - 10.1016/j.transproceed.2004.06.064
M3 - Artículo
C2 - 15350444
AN - SCOPUS:4444373657
SN - 0041-1345
VL - 36
SP - 1661
EP - 1663
JO - Transplantation Proceedings
JF - Transplantation Proceedings
IS - 6
ER -